日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Phase I/II Study of AXL-Specific Antibody-Drug Conjugate Enapotamab Vedotin in Patients with Advanced Solid Tumors

AXL特异性抗体药物偶联物Enapotamab Vedotin治疗晚期实体瘤患者的I/II期研究

Rohrberg, Kristoffer Staal; Lopez, Juanita S; Milhem, Mohammed M; Blank, Christian U; Reijers, Irene; Thistlethwaite, Fiona; Plummer, Ruth; Piha-Paul, Sarina A; Jänne, Pasi A; Shum, Elaine; Shaw, Heather M; Debruyne, Philip R; Lao, Cristopher; Baurain, Jean-Francois; Choe, Jennifer H; Gort, Eelke; Zhao, Yujie; Jerusalem, Guy; Schöffski, Patrick; Chen, Andrew William; Cohen, Eric A; Mankowski, Walter C; Roshkovan, Leonid; Katz, Sharyn I; Kontos, Despina; Brady, Lauren K; Qutaish, Mohammed; Castro, Patricia Garrido; Pencheva, Nora; Bajaj, Gaurav; Fu, Yali; Windfeld, Kristian; Reiter, Panagiota; Jure-Kunkel, Maria; Higgs, Brandon W; Amiri, Katayoun I; Ahmadi, Tahamtan; Forssmann, Ulf; Ramalingam, Suresh S; Vergote, Ignace

Tebentafusp: a first-in-class treatment for metastatic uveal melanoma

Tebentafusp:治疗转移性葡萄膜黑色素瘤的首创疗法

Howlett, Sarah; Carter, Thomas J; Shaw, Heather M; Nathan, Paul D

Total serum N-glycans associate with response to immune checkpoint inhibition therapy and survival in patients with advanced melanoma

总血清N-糖链与晚期黑色素瘤患者对免疫检查点抑制剂治疗的反应和生存率相关

Visconti, Alessia; Rossi, Niccolò; Deriš, Helena; Lee, Karla A; Hanić, Maja; Trbojević-Akmačić, Irena; Thomas, Andrew M; Bolte, Laura A; Björk, Johannes R; Hooiveld-Noeken, Jahlisa S; Board, Ruth; Harland, Mark; Newton-Bishop, Julia; Harries, Mark; Sacco, Joseph J; Lorigan, Paul; Shaw, Heather M; de Vries, Elisabeth G E; Fehrmann, Rudolf S N; Weersma, Rinse K; Spector, Tim D; Nathan, Paul; Hospers, Geke A P; Sasieni, Peter; Bataille, Veronique; Lauc, Gordan; Falchi, Mario

Cross-cohort gut microbiome associations with immune checkpoint inhibitor response in advanced melanoma

跨队列肠道微生物组与晚期黑色素瘤免疫检查点抑制剂反应的关联

Lee, Karla A; Thomas, Andrew Maltez; Bolte, Laura A; Björk, Johannes R; de Ruijter, Laura Kist; Armanini, Federica; Asnicar, Francesco; Blanco-Miguez, Aitor; Board, Ruth; Calbet-Llopart, Neus; Derosa, Lisa; Dhomen, Nathalie; Brooks, Kelly; Harland, Mark; Harries, Mark; Leeming, Emily R; Lorigan, Paul; Manghi, Paolo; Marais, Richard; Newton-Bishop, Julia; Nezi, Luigi; Pinto, Federica; Potrony, Miriam; Puig, Susana; Serra-Bellver, Patricio; Shaw, Heather M; Tamburini, Sabrina; Valpione, Sara; Vijay, Amrita; Waldron, Levi; Zitvogel, Laurence; Zolfo, Moreno; de Vries, Elisabeth G E; Nathan, Paul; Fehrmann, Rudolf S N; Bataille, Véronique; Hospers, Geke A P; Spector, Tim D; Weersma, Rinse K; Segata, Nicola

Circulating inflammatory proteins associate with response to immune checkpoint inhibition therapy in patients with advanced melanoma

循环炎症蛋白与晚期黑色素瘤患者对免疫检查点抑制剂疗法的反应相关

Rossi, Niccolò; Lee, Karla A; Bermudez, Maria V; Visconti, Alessia; Thomas, Andrew Maltez; Bolte, Laura A; Björk, Johannes R; de Ruijter, Laura Kist; Newton-Bishop, Julia; Harland, Mark; Shaw, Heather M; Harries, Mark; Sacco, Joseph; Board, Ruth; Lorigan, Paul; de Vries, Elisabeth G E; Segata, Nicola; Taams, Leonie; Papa, Sophie; Spector, Tim D; Nathan, Paul; Weersma, Rinse K; Hospers, Geke A P; Fehrmann, Rudolf S N; Bataille, Veronique; Falchi, Mario

Oncogenic B-RAF(V600E) signaling induces the T-Box3 transcriptional repressor to repress E-cadherin and enhance melanoma cell invasion.

致癌的 B-RAF(V600E) 信号诱导 T-Box3 转录抑制因子抑制 E-钙黏蛋白并增强黑色素瘤细胞侵袭

Boyd Suzanah C, Mijatov Branka, Pupo Gulietta M, Tran Sieu L, Gowrishankar Kavitha, Shaw Heather M, Goding Colin R, Scolyer Richard A, Mann Graham J, Kefford Richard F, Rizos Helen, Becker Therese M

Emerging treatment options for recurrent ovarian cancer: the potential role of olaparib

复发性卵巢癌的新兴治疗选择:奥拉帕尼的潜在作用

Shaw, Heather M; Hall, Marcia

The retinoblastoma protein modulates Tbx2 functional specificity

视网膜母细胞瘤蛋白调节Tbx2的功能特异性

Vance, Keith W; Shaw, Heather M; Rodriguez, Mercedes; Ott, Sascha; Goding, Colin R